Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists

Samiksha Fouzdar Jain1 Ophthalmology Department, Children’s Hospital and Medical Center, Omaha, NE, USA

Helen H Song2 Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, NE, USA

Shaza N Al-Holou2 Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, NE, USA

Linda A Morgan1 Ophthalmology Department, Children’s Hospital and Medical Center, Omaha, NE, USACorrespondence[email protected]

Donny W Suh1 Ophthalmology Department, Children’s Hospital and Medical Center, Omaha, NE, USA;2 Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, NE, USA

Pages 1003-1009 | Published online: 28 May 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

WallaceDKWuKYCurrent and future trends in treatment of severe retinopathy of prematurityClin Perinatol201340229731023719311
PubMed Web of Science ®Google Scholar
GoodWVEarly Treatment for Retinopathy of Prematurity Cooperative GroupFinal results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trialTrans Am Ophthalmol Soc200410223324815747762
PubMedGoogle Scholar
YonekawaYWuWCNitulescuCEProgressive retinal detachment in infants with retinopathy of prematurity treated with intravitreal bevacizumab or ranibizumabRetina Epub201753
Web of Science ®Google Scholar
WuWCKuoHKYehPTYangCMLaiCCChenSNAn updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in TaiwanAm J Ophthalmol2013155115015822967867
PubMed Web of Science ®Google Scholar
Mintz-HittnerHAKennedyKAChuangAZBEAT-ROP Cooperative GroupEfficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurityN Engl J Med2011364760361521323540
PubMed Web of Science ®Google Scholar
HuJBlairMPShapiroMJLichtensteinSJGalassoJMKapurRReactivation of retinopathy of prematurity after bevacizumab injectionArch Ophthalmol201213081000100622491394
PubMed Web of Science ®Google Scholar
WuWCYehPTChenSNYangCMLaiCCKuoHKEffects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in TaiwanOphthalmology2011118117618320673589
PubMed Web of Science ®Google Scholar
NazariHModarresMParvareshMMGhasemi FalavarjaniKIntravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhageGraefes Arch Clin Exp Ophthalmol2010248121713171820582706
PubMed Web of Science ®Google Scholar
DortaPKychenthalATreatment of type 1 retinopathy of prematurity with intravitreal bevacizumab (Avastin)Retina201030Suppl 4S24S3120224475
PubMedGoogle Scholar
BreierGAlbrechtUSterrerSRisauWExpression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiationDevelopment199211425215321592003
PubMed Web of Science ®Google Scholar
HärdALHellströmAOn safety, pharmacokinetics and dosage of bevacizumab in ROP treatment – a reviewActa Paediatr2011100121523152721854449
PubMed Web of Science ®Google Scholar
LawJCRecchiaFMMorrisonDGDonahueSPEstesRLIntravitreal bevacizumab as adjunctive treatment for retinopathy of prematurityJ AAPOS201014161020227614
PubMed Web of Science ®Google Scholar
Mintz-HittnerHAKuffelRRJrIntravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone IIRetina200828683183818536599
PubMed Web of Science ®Google Scholar
Martínez-CastellanosMASchwartzSHernández-RojasMLLong-term effect of antiangiogenic therapy for retinopathy of prematurity up to 5 years of follow-upRetina201333232933823099498
PubMed Web of Science ®Google Scholar
LienRYuMHHsuKHNeurodevelopmental outcomes in infants with retinopathy of prematurity and bevacizumab treatmentPLoS One2016111e014801926815000
PubMed Web of Science ®Google Scholar
WuWCLienRLiaoPJSerum levels of vascular endothelial growth factor and related factors after intravitreous bevacizumab injection for retinopathy of prematurityJAMA Ophthalmol2015133439139725569026
PubMed Web of Science ®Google Scholar
PatelCKFungTHMMuqitMMKNon-contact ultra-widefield imaging of retinopathy of prematurity using the Optos dual wavelength scanning laser ophthalmoscopeEye201327558959623519279
PubMed Web of Science ®Google Scholar
Mintz-HittnerHAKennedyKAChuangAZEfficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurityN Engl J Med2011364760361521323540
PubMed Web of Science ®Google Scholar
HarderBCvon BaltzSJonasJBSchlichtenbredeFCIntravitreal low-dosage bevacizumab for retinopathy of prematurityActa Ophthalmol201492657758124020921
PubMed Web of Science ®Google Scholar
WallaceDKKrakerRTFreedmanSFAssessment of lower doses of intravitreous bevacizumab for retinopathy of prematurity: a phase 1 dosing studyJAMA Ophthalmol2017135665465628448664
PubMed Web of Science ®Google Scholar
StahlAKrohneTUEterNComparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity: a randomized clinical trialJAMA Pediatr2018172327828629309486
PubMed Web of Science ®Google Scholar
LeeBJKimJHHeoHYuYSDelayed onset atypical vitreoretinal traction band formation after an intravitreal injection of bevacizumab in stage 3 retinopathy of prematurityEye201226790391022699977
PubMed Web of Science ®Google Scholar
LeporeDQuinnGEMolleFFollow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findingsOphthalmology2018125221822628867130
PubMed Web of Science ®Google Scholar
HarperCA3rdWrightLMYoungRCReadSPChangEYFluorescein angiographic evaluation of peripheral retinal vasculature after primary intravitreal ranibizumab for retinopathy of prematurityRetina Epub201813
Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date